Pharmacy Update
Disclaimer: We are getting frequent COVID-related questions about drug concerns and potential interactions. This information is as of June 24, 2020. We will do our best to keep you up to date with this ever evolving situation. This is the most update information at the time of publication.
Note: There are no Food and Drug Administration
(FDA) approved therapies for treatment or prevention of COVID-19. If at all possible, it is best to have patients enrolled in a clinical trial.
In this issue:
TOCILIZUMAB FOR THE TREATMENT OF SEVERE COVID-19: A RETROSPECTIVE COHORT STUDY -
A retrospective cohort study did not show statistically significant improvements in median time to clinical improvement in patients with severe COVID-19 who required mechanical ventilation.
HYPERTENSION AND COVID-19 -
A Chinese retrospective, observational study was published on June 4, 2020 in the European Heart Journal which suggests that patients hospitalized with untreated hypertension have a significantly higher rate of mortality than those with controlled hypertension.
